Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune Smaaland

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 18, 2012
miRNA expression profiling for identification of potential breast cancer biomarkersKjersti Tjensvoll, Kine N Svendsen, James M Reuben, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 7, 2012
Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutationsOddmund Nordgård, Satu Oltedal, Emiel A M Janssen, et al.
Annals of Surgery|May 21, 2010
Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCRSatu Oltedal, Bjørnar Gilje, Hartwig Kørner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 17, 2004
Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumorTeresa G Granda, Xu-Hui Liu, Rune Smaaland, et al.
Breast Cancer Research and Treatment|April 9, 2011
Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patientsBjørnar Gilje, Oddmund Nordgård, Kjersti Tjensvoll, et al.
BMC Cancer|May 30, 2012
Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcomeKjersti Tjensvoll, Satu Oltedal, Reino Heikkilä, et al.
Plos One|May 15, 2013
Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancerOddmund Nordgård, Gurpartap Singh, Steinar Solberg, et al.
Histopathology|September 12, 2012
Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancerEinar Gudlaugsson, Ivar Skaland, Emiel A M Janssen, et al.
BMC Gastroenterology|February 9, 2018
Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnosticsSatu Oltedal, Ivar Skaland, Jodi Maple-Grødem, et al.
Clinical Breast Cancer|October 6, 2010
Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patientsKjersti Tjensvoll, Satu Oltedal, Ragne K Farmen, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 18, 2012
miRNA expression profiling for identification of potential breast cancer biomarkersKjersti Tjensvoll, Kine N Svendsen, James M Reuben, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 7, 2012
Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutationsOddmund Nordgård, Satu Oltedal, Emiel A M Janssen, et al.
Annals of Surgery|May 21, 2010
Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCRSatu Oltedal, Bjørnar Gilje, Hartwig Kørner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 17, 2004
Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumorTeresa G Granda, Xu-Hui Liu, Rune Smaaland, et al.
Breast Cancer Research and Treatment|April 9, 2011
Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patientsBjørnar Gilje, Oddmund Nordgård, Kjersti Tjensvoll, et al.
BMC Cancer|May 30, 2012
Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcomeKjersti Tjensvoll, Satu Oltedal, Reino Heikkilä, et al.
Plos One|May 15, 2013
Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancerOddmund Nordgård, Gurpartap Singh, Steinar Solberg, et al.
Histopathology|September 12, 2012
Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancerEinar Gudlaugsson, Ivar Skaland, Emiel A M Janssen, et al.
BMC Gastroenterology|February 9, 2018
Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnosticsSatu Oltedal, Ivar Skaland, Jodi Maple-Grødem, et al.
Clinical Breast Cancer|October 6, 2010
Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patientsKjersti Tjensvoll, Satu Oltedal, Ragne K Farmen, et al.
Pageof 4